Sign Out
Pregnancy: The safety of S(-) Amlodipine in human pregnancy has not been established.
Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and foetus.
Lactation: It is not known whether S(-) Amlodipine is excreted in breast milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with S(-) Amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of S(-) Amlodipine therapy to the mother.
Fertility: Reversible biochemical changes in the head of spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effect of S(-) Amlodipine on fertility.
